Table of Contents
Chapter 1. Industry Outlook
1.1. Market Overview
1.2. Platform Trials Workflow Analysis
1.3. Industry Ecosystem Analysis
1.4. Technology Landscape
1.5. Market Dynamics
1.5.1. Market Driver Analysis
1.5.1.1. Growing Focus on Precision Medicine
1.5.1.2. Advancements in Technology
1.5.1.3. Favorable Regulatory scenarios
1.5.1.4. Rising Growing investment and preference by Government Authorities and Private Sponsors
1.5.2. Market Restraints Analysis
1.5.2.1. Data integrity and Security Concerns
1.5.2.2. Patient Recruitment Complexity
1.5.2.3. Limited availability of skilled workforce
1.6. Market Entry Strategies
1.7. Revenue Model Analysis
1.8. Regulatory Framework
1.9. Case Studies of Key Platform Trials
Chapter 2. Platform Trials Trend Analysis by Therapeutic Area
2.1. Key Therapeutic Area Dynamics
2.1.1. Oncology
2.1.2. Neurology
2.1.3. Infectious Diseases
2.1.4. Cardiovascular Diseases
2.1.5. Others
Chapter 3. Platform Trials Trend Analysis by Study Design
3.1. Key Study Design Dynamics
3.1.1. Adaptive Trials
3.1.2. Basket Trials
3.1.3. Umbrella Trials
Chapter 4. Platform Trials Trend Analysis by Region
4.1. Key Regional Dynamics
4.1.1. North America
4.1.2. Europe
4.1.3. Asia Pacific
4.1.4. Rest of World